Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography
Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography
Status: Enrolling
Updated:  10/1/2015
Tripler Army Medical Center
mi
from
Tripler, HI
Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography
Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography
Status: Enrolling
Updated: 10/1/2015
Tripler Army Medical Center
mi
from
Tripler, HI
Click here to add this to my saved trials
Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
Status: Enrolling
Updated:  10/2/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
Status: Enrolling
Updated: 10/2/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Proton Radiation Therapy for Pituitary Adenoma
Clinical Outcomes Study of Proton Radiation Therapy for Pituitary Adenoma
Status: Enrolling
Updated:  10/2/2015
University of Florida Proton Therapy Institute
mi
from
Jacksonville, FL
Proton Radiation Therapy for Pituitary Adenoma
Clinical Outcomes Study of Proton Radiation Therapy for Pituitary Adenoma
Status: Enrolling
Updated: 10/2/2015
University of Florida Proton Therapy Institute
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Ketoconazole and Dexamethasone in Prostate Cancer
An Endocrinologically and Pharmacologically Directed Trial of Ketoconazole and Corticosteroids in Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
University of California at San Francisco
mi
from
San Francisco, CA
Ketoconazole and Dexamethasone in Prostate Cancer
An Endocrinologically and Pharmacologically Directed Trial of Ketoconazole and Corticosteroids in Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Park Ridge, IL
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Baltimore, MD
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Boston, MA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Dallas, TX
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Norfolk, VA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Tucson, AZ
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Oxnard, CA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Oxnard, CA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Santa Monica, CA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Santa Rosa, CA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Wellington, FL
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Wellington, FL
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Atlanta, GA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Meridian, ID
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Melrose Park, IL
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Melrose Park, IL
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Jeffersonville, IN
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Jeffersonville, IN
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Rockville, MD
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Jefferson City, MO
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Jefferson City, MO
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Las Vegas, NV
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Hackensack, NJ
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
LawrenceVille, NJ
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
LawrenceVille, NJ
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Buffalo, NY
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Poughkeepsie, NY
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Concord, NC
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Concord, NC
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Durham, NC
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Raleigh, NC
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Springfield, OR
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Springfield, OR
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Bala Cynwyd, PA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Bala Cynwyd, PA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Lancaster, PA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Lancaster, PA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Myrtle Beach, SC
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Nashville, TN
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Salt Lake, UT
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Salt Lake, UT
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Fairfax, VA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Salem, VA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Salem, VA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
mi
from
Burien, WA
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
mi
from
Burien, WA
Click here to add this to my saved trials
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
mi
from
Ciudad Autonoma de Buenos Aires,
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
mi
from
Ciudad Autonoma de Buenos Aires,
Click here to add this to my saved trials
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Alaska Clinical Research Center, LLC
mi
from
Anchorage, AK
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Alaska Clinical Research Center, LLC
mi
from
Anchorage, AK
Click here to add this to my saved trials
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Southern California Permanente Medical Group
mi
from
Anaheim, CA
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Southern California Permanente Medical Group
mi
from
Anaheim, CA
Click here to add this to my saved trials
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Southern California Permanente Medical Group
mi
from
Baldwin Park, CA
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Southern California Permanente Medical Group
mi
from
Baldwin Park, CA
Click here to add this to my saved trials
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Southern California Permanente Medical Group
mi
from
BellFlower, CA
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Southern California Permanente Medical Group
mi
from
BellFlower, CA
Click here to add this to my saved trials
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Pacific Clinical Center
mi
from
Beverly Hills, CA
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Pacific Clinical Center
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
South County Hematology/Oncology
mi
from
Chula Vista, CA
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
South County Hematology/Oncology
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Southern California Permanente Medical Group
mi
from
Fontana, CA
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Southern California Permanente Medical Group
mi
from
Fontana, CA
Click here to add this to my saved trials
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Southern California Permanente Medical Group
mi
from
Irvine, CA
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Southern California Permanente Medical Group
mi
from
Irvine, CA
Click here to add this to my saved trials
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
Cancer Center Oncology Medical Group
mi
from
La Mesa, CA
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
Cancer Center Oncology Medical Group
mi
from
La Mesa, CA
Click here to add this to my saved trials
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
North County Oncology Medical Clinic Inc
mi
from
Oceanside, CA
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
North County Oncology Medical Clinic Inc
mi
from
Oceanside, CA
Click here to add this to my saved trials
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  10/2/2015
San Bernardino Urological Associates
mi
from
San Bernardino, CA
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 10/2/2015
San Bernardino Urological Associates
mi
from
San Bernardino, CA
Click here to add this to my saved trials